Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer

University of California, San Diego · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
prostate-cancer
metastatic castration-resistant prostate cancer, prostate cancer, docetaxel, wnt pathway, cirmtuzumab, ror1, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805793
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.